Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

Life expectancy in New York City has been falling. A new plan to address it includes basic income, prescribing parks, and ...

A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemming from STAT reporting on the firm's use of ...

This is common. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

The Howard Hughes Medical Institute abruptly ended a $60 million program to improve the retention of diverse college students ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.